Admission levels of ln-transformed cystatin C were also positively associated with the mortality among COVID-19 patients, which indicated that higher ln-transformed cystatin C levels might imply higher death rates during hospitalization of patients with COVID-19 (Figure 1(b)). The gene discussed is CST3; the disease is COVID-19.